This study is investigating a non-surgical treatment called radiofrequency ablation (RFA) using the Mygen V-1000 RF system for LatinX patients who have benign (non-cancerous) thyroid nodules that are causing symptoms like cosmetic concerns, pressure, or hormone issues. RFA uses heat to shrink the nodule and avoids the risks of surgery. The study aims to see if this procedure is a safe and effective alternative to surgery for this specific patient group. To join, you must be 18 to 90 years old, identify as LatinX, and have a benign, symptomatic thyroid nodule that meets certain ultrasound criteria. The study will measure how much the thyroid nodule shrinks over 2 years to determine if the treatment is successful. The current recruitment status is unclear.

Study design

This is an interventional study with a planned enrollment of 44 participants. The phase of the study is not specified.

What's involved

If you join, you will complete questionnaires, have blood tests, undergo thyroid ultrasounds, and receive the radiofrequency ablation treatment. You will be followed for 2 years.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 2 years after treatment to measure changes in thyroid nodule volumes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.